SCHEMBL24677760

SCHEMBL24677760

COC(=O)c1ccccc1COc1ccc(C)c(C=O)c1F

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 5/20 0.46
ALDH1A1 P00352 5/20 0.41
LMNA P02545 1/20 0.41
MAPT P10636 3/20 0.40
HSP90AA1 P07900 2/20 0.40
HPGD P15428 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
SGMS2 Q8NHU3 1/20 0.37
GAA P10253 1/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
KMT2A Q03164 1/20 0.37
TSPO P30536 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30447357 1.00 MRGPRX4 (0.46) MRGPRX4ALDH1A1LMNAMAPTHSP90AA1
SCHEMBL24677759 0.89 MRGPRX4 (0.47) MRGPRX4ALDH1A1LMNAMAPTHSP90AA1
SCHEMBL24677758 0.88 MRGPRX4 (0.46) MRGPRX4ALDH1A1LMNAMAPTHSP90AA1
SCHEMBL24677896 0.88 MRGPRX4 (0.51) MRGPRX4ALDH1A1HTT
SCHEMBL29831705 0.88 MRGPRX4 (0.51) MRGPRX4ALDH1A1HTT
SCHEMBL25950573 0.81 ALDH1A1 (0.42) MRGPRX4ALDH1A1LMNAMAPTHSP90AA1
SCHEMBL25950565 0.80 LMNA (0.42) MRGPRX4ALDH1A1LMNAMAPTHSP90AA1
SCHEMBL30558899 0.79 HTT (0.50) MRGPRX4ALDH1A1MAPTCYP2C9SMN1; SMN2
SCHEMBL24677801 0.79 HTT (0.50) MRGPRX4ALDH1A1MAPTCYP2C9SMN1; SMN2
SCHEMBL26507019 0.77 RPS6KA1 (0.42) MRGPRX4ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227493-A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS ELI LILLY AND COMPANY 2023-07-20 US disclosed
US-20230227493-A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS ELI LILLY AND COMPANY 2023-07-20 US disclosed
US-20220306681-A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS ELI LILLY AND COMPANY 2022-09-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227493-A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS NR3C1, MC2R, NR3C2 MRGPRX4 28/4885ALDH1A1 2971/4885LMNA 4331/4885
US-20220306681-A1 CARBOXY SUBSTITUTED GLUCOCORTICOID RECEPTOR AGONISTS NR3C1, MC2R, NR3C2 MRGPRX4 28/4885ALDH1A1 2971/4885LMNA 4331/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.